Selected article for: "EBOV minigenome and minigenome replication"

Author: Shu, Ting; Gan, Tianyu; Bai, Peng; Wang, Xiaotong; Qian, Qi; Zhou, Hui; Cheng, Qi; Qiu, Yang; Yin, Lei; Zhong, Jin; Zhou, Xi
Title: Ebola virus VP35 has novel NTPase and helicase-like activities
  • Document date: 2019_6_20
  • ID: u3pxycqh_62
    Snippet: Moreover, our work shows that GuHCl, an FDA-approved small molecule drug, is able to inhibit the NTPase/helicaselike activities of VP35 in vitro, and more importantly, the replication and transcription of a stable EBOV minigenome replicon in cultured human cells......
    Document: Moreover, our work shows that GuHCl, an FDA-approved small molecule drug, is able to inhibit the NTPase/helicaselike activities of VP35 in vitro, and more importantly, the replication and transcription of a stable EBOV minigenome replicon in cultured human cells.

    Search related documents:
    Co phrase search for related documents
    • EBOV minigenome and NTPase helicaselike: 1
    • EBOV minigenome and NTPase helicaselike activity: 1
    • EBOV minigenome and small molecule: 1
    • EBOV minigenome and transcription replication: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • EBOV minigenome replicon and transcription replication: 1, 2, 3, 4, 5, 6
    • human cell and small molecule: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • human cell and small molecule drug: 1, 2, 3, 4
    • human cell and transcription replication: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • NTPase helicaselike activity and transcription replication: 1
    • NTPase helicaselike and transcription replication: 1
    • small molecule and transcription replication: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16